These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 2462416

  • 1. Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.
    Gonias SL, Figler NL.
    Biochem J; 1988 Oct 15; 255(2):725-30. PubMed ID: 2462416
    [Abstract] [Full Text] [Related]

  • 2. Regulation of streptokinase-human plasmin complex by the plasma proteinase inhibitors alpha 2-antiplasmin and alpha 2-macroglobulin is species specific and temperature dependent.
    Gonias SL, Figler NL, Braud LL.
    Blood; 1988 Nov 15; 72(5):1658-64. PubMed ID: 2460159
    [Abstract] [Full Text] [Related]

  • 3. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK, Gonias SL.
    Biochem J; 1991 Apr 01; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [Abstract] [Full Text] [Related]

  • 4. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK, Wolf B, Gonias SL.
    Thromb Res; 1990 Aug 01; 59(3):449-62. PubMed ID: 1700488
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK, Yoo JK, Webb DJ, Gonias SL.
    Biochem J; 1993 Feb 01; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [Abstract] [Full Text] [Related]

  • 6. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K, Léránt I, Tenekejiev K, Machovich R.
    J Biol Chem; 1994 Jun 24; 269(25):17030-4. PubMed ID: 7516329
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
    Hall SW, Humphries JE, Gonias SL.
    J Biol Chem; 1991 Jul 05; 266(19):12329-36. PubMed ID: 1712017
    [Abstract] [Full Text] [Related]

  • 8. An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice.
    LaMarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL.
    J Clin Invest; 1991 Jan 05; 87(1):39-44. PubMed ID: 1702100
    [Abstract] [Full Text] [Related]

  • 9. Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor.
    Korninger C, Collen D.
    Thromb Haemost; 1981 Oct 05; 46(3):662-5. PubMed ID: 6171907
    [Abstract] [Full Text] [Related]

  • 10. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.
    Gonias SL, Balber AE, Hubbard WJ, Pizzo SV.
    Biochem J; 1983 Jan 01; 209(1):99-105. PubMed ID: 6189480
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K, Komorowicz E, Machovich R.
    Blood Coagul Fibrinolysis; 1994 Dec 01; 5(6):905-11. PubMed ID: 7534486
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppressive properties of electrophoretically "slow" and "fast" form alpha 2-macroglobulin. Effects on cell-mediated cytotoxicity and (allo-) antigen-induced T cell proliferation.
    Petersen CM, Ejlersen E, Moestrup SK, Jensen PH, Sand O, Sottrup-Jensen L.
    J Immunol; 1989 Jan 15; 142(2):629-35. PubMed ID: 2463311
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inactivation of alpha 2-antiplasmin by limited reaction with cis-dichlorodiammineplatinum (II).
    Geary WA, Gonias SL.
    Biochim Biophys Acta; 1989 Jan 19; 994(1):1-6. PubMed ID: 2521201
    [Abstract] [Full Text] [Related]

  • 17. Binding of tumor necrosis factor alpha to activated forms of human plasma alpha 2 macroglobulin.
    Wollenberg GK, LaMarre J, Rosendal S, Gonias SL, Hayes MA.
    Am J Pathol; 1991 Feb 19; 138(2):265-72. PubMed ID: 1704186
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the structure and aspects of the proteinase-binding properties of cystic fibrotic alpha-macroglobulin with normal alpha 2-macroglobulin.
    Roberts RC, Nelles LP, Hall PK, Salvesen GS, Mischler E.
    Pediatr Res; 1982 Jun 19; 16(6):416-23. PubMed ID: 6179035
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin enhances antibody formation.
    Chu CT, Oury TD, Enghild JJ, Pizzo SV.
    J Immunol; 1994 Feb 15; 152(4):1538-45. PubMed ID: 7509826
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.